SCHEMBL22200599

SCHEMBL22200599

CC(C)n1c(=O)c(-c2ccc(NSCc3ccc(F)cc3)c(F)c2)nc2cnc(NC3CCC(N(C)C)C(F)C3)nc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 5/20 0.51
CASP1 P29466 9/20 0.36
HIF1A Q16665 8/20 0.36
ALDH1A1 P00352 8/20 0.36
HSD17B10 Q99714 8/20 0.36
CYP1A2 P05177 8/20 0.36
CASP7 P55210 8/20 0.36
USP2 O75604 8/20 0.36
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
CYP3A4 P08684 4/20 0.35
CYP2C9 P11712 3/20 0.35
ALOX15 P16050 3/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 2/20 0.35
CYP2C19 P33261 1/20 0.34
MAPK8 P45983 5/20 0.34
MAPK9 P45984 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200742 0.95 ERN1 (0.49) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22200595 0.89 ERN1 (0.49) ERN1CASP1ALDH1A1HSD17B10CYP1A2
SCHEMBL22190947 0.88 ERN1 (0.66) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22200488 0.88 ERN1 (0.66) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22200487 0.88 ERN1 (0.66) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL29356049 0.88 ERN1 (0.66) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22200381 0.88 ERN1 (0.47) ERN1CASP1ALDH1A1HSD17B10CYP1A2
SCHEMBL25035553 0.83 ERN1 (0.64) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22191557 0.83 ERN1 (0.64) ERN1CASP1HIF1AALDH1A1HSD17B10
SCHEMBL22200490 0.83 ERN1 (0.64) ERN1CASP1HIF1AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed